: ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging / Marsden, T., Mccartan, N., Hadley, J., Tuck, S., Brown, L., Haire, A.J., Moss, C.L., Green, S., Van Hemelrijck, M., Coolen, T., Santaolalla, A., Isaac, E., Brembilla, G., Kopcke, D., Giganti, F., Sidhu, H., Punwani, S., Emberton, M., Moore, C.M.. - In: EUROPEAN UROLOGY FOCUS. - ISSN 2405-4569. - 7:3(2021), pp. 503-505. [10.1016/j.euf.2021.03.027]
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging
Brembilla, Giorgio;
2021-01-01
Abstract
: ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2405456921001061-main.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
237.75 kB
Formato
Adobe PDF
|
237.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
